BIOLOGICAL · Unmapped registry intervention
chemotherapy followed dendritic cells
Find medicine records ·
Find other trials using this name
Clinical trial
Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
NCT02669719
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
pemetrexed and carboplatin
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
Shanghai Chest Hospitallead sponsor
SOTIO a.s.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02669719 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.